Nike, Inc. (NYSE: NKE) is a Beaverton, Oregon based American multinational corporation that designs, develops, manufactures and sells athletic footwear, apparel, equipment and accessories …
In a research note released today, Janney Capital analyst Kimberly Lee maintained a Neutral rating on PDL Biopharma (PDLI) with a $7 fair value, following the reporting that the …
In a research note published today, Janney Capital analyst Kimberly Lee maintained a Buy rating on Cell Therapeutics (NASDAQ:CTIC) with a $4 fair value, following collaboration agreement with …
In a research note released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on Agile Therapeutics (NASDAQ:AGRX) with an $18 fair value …
In a report released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on NPS Pharmaceuticals (NASDAQ:NPSP) with a $37 fair value, following last friday’s news …
In a research note published yesterday, Janney Capital analyst Kimberly Lee reiterated a Buy rating on NPS Pharma (NASDAQ:NPSP) with a $37 fair …
In a research report pubished yesterday, Janney Capital analyst Kimberly Lee maintained a Buy rating on Medivation (NASDAQ:MDVN) with a $110 fair value, …
In a research report released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on NPS Pharmaceuticals (NPSP) with a $37 fair value, ahead of the company’s upcoming …
Amicus Therapeutics (FOLD) today announced robust 18-month data from the migalastat monotherapy Study 012 in Fabry patients with amenable mutations. Migalastat met the …
In a research note released August 8, Janney Capital analyst Kimberly Lee maintained a Buy rating on Raptor Pharmaceuticals Corp. (RPTP) with a …